Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Kawamura

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Micromachines|August 26, 2020
Recent Developments on Modeling for a 3-DOF Micro-Hand Based on AI MethodsShuhei Kawamura, Mingcong Deng
Nature|March 24, 2016
Nineteen-step total synthesis of (+)-phorbolShuhei Kawamura, Hang Chu, Jakob Felding, et al.
Organic & Biomolecular Chemistry|August 30, 2013
Design and synthesis of the stabilized analogs of belactosin A with the unnatural cis-cyclopropane structureShuhei Kawamura, Yuka Unno, Akira Asai, et al.
Journal of Medicinal Chemistry|February 15, 2014
Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronatesShuhei Kawamura, Yuka Unno, Akira Asai, et al.
Bioorganic & Medicinal Chemistry|May 13, 2014
Development of a new class of proteasome inhibitors with an epoxyketone warhead: Rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketonesShuhei Kawamura, Yuka Unno, Akira Asai, et al.
Bioorganic & Medicinal Chemistry|February 16, 2016
Synthesis and pharmacological evaluation of nucleoside prodrugs designed to target siderophore biosynthesis in Mycobacterium tuberculosisSurendra Dawadi, Shuhei Kawamura, Anja Rubenstein, et al.
Journal of Medicinal Chemistry|April 14, 2018
Ligand-Phospholipid Conjugation: A Versatile Strategy for Developing Long-Acting Ligands That Bind to Membrane Proteins by Restricting the Subcellular Localization of the LigandShuhei Kawamura, Yoshihiko Ito, Takatsugu Hirokawa, et al.
Chemical Communications (Cambridge, England)|January 24, 2014
Rational hopping of a peptidic scaffold into non-peptidic scaffolds: structurally novel potent proteasome inhibitors derived from a natural product, belactosin AShuhei Kawamura, Yuka Unno, Takatsugu Hirokawa, et al.
Journal of Medicinal Chemistry|April 4, 2013
Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of actionShuhei Kawamura, Yuka Unno, Anja List, et al.
Journal of Medicinal Chemistry|July 11, 2013
Investigation of the noncovalent binding mode of covalent proteasome inhibitors around the transition state by combined use of cyclopropylic strain-based conformational restriction and computational modelingShuhei Kawamura, Yuka Unno, Motohiro Tanaka, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Micromachines|August 26, 2020
Recent Developments on Modeling for a 3-DOF Micro-Hand Based on AI MethodsShuhei Kawamura, Mingcong Deng
Nature|March 24, 2016
Nineteen-step total synthesis of (+)-phorbolShuhei Kawamura, Hang Chu, Jakob Felding, et al.
Organic & Biomolecular Chemistry|August 30, 2013
Design and synthesis of the stabilized analogs of belactosin A with the unnatural cis-cyclopropane structureShuhei Kawamura, Yuka Unno, Akira Asai, et al.
Journal of Medicinal Chemistry|February 15, 2014
Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronatesShuhei Kawamura, Yuka Unno, Akira Asai, et al.
Bioorganic & Medicinal Chemistry|May 13, 2014
Development of a new class of proteasome inhibitors with an epoxyketone warhead: Rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketonesShuhei Kawamura, Yuka Unno, Akira Asai, et al.
Bioorganic & Medicinal Chemistry|February 16, 2016
Synthesis and pharmacological evaluation of nucleoside prodrugs designed to target siderophore biosynthesis in Mycobacterium tuberculosisSurendra Dawadi, Shuhei Kawamura, Anja Rubenstein, et al.
Journal of Medicinal Chemistry|April 14, 2018
Ligand-Phospholipid Conjugation: A Versatile Strategy for Developing Long-Acting Ligands That Bind to Membrane Proteins by Restricting the Subcellular Localization of the LigandShuhei Kawamura, Yoshihiko Ito, Takatsugu Hirokawa, et al.
Chemical Communications (Cambridge, England)|January 24, 2014
Rational hopping of a peptidic scaffold into non-peptidic scaffolds: structurally novel potent proteasome inhibitors derived from a natural product, belactosin AShuhei Kawamura, Yuka Unno, Takatsugu Hirokawa, et al.
Journal of Medicinal Chemistry|April 4, 2013
Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of actionShuhei Kawamura, Yuka Unno, Anja List, et al.
Journal of Medicinal Chemistry|July 11, 2013
Investigation of the noncovalent binding mode of covalent proteasome inhibitors around the transition state by combined use of cyclopropylic strain-based conformational restriction and computational modelingShuhei Kawamura, Yuka Unno, Motohiro Tanaka, et al.
Pageof 3